Facebook picto   picto linkdink   picto tiwter

News & Media

Sep 24, 2015
Focal One® HIFU Device Adopted by Medipole Group in France

EDAP-TMS
EDAP's Focal One® HIFU Device Adopted by Medipole Group in France

With the recent Focal One sale to Medipôle Partenaires, one of the largest private Hospital groups in France, EDAP is clearly expanding its HIFU penetration in the French territory. Medipôle Partenaires will be using the Focal One device on a mobile basis with the equipment being shared between more than ten private urology centers throughout the country. EDAP and Medipôle Partenaires are now conducting a dedicated, intensive training program for the group's urologists. The adoption of HIFU for prostate cancer in France is being supported by the French authorities' decision to reimburse HIFU treatment within the framework of innovative technologies programs ("Forfait Innovation").